VLEEMO ONCOLOGY CENTRE OF EXCELLENCE
VLEEMO ONCOLOGY CENTRE OF EXCELLENCE
VLEEMO appointed me to build the strategic and commercial blueprint for a proposed 80-bed greenfield Oncology Centre of Excellence and advanced nuclear-medicine facility in Phuket.
The development integrated a premium patient journey, medical-tourism strategy, 7-year commercial model, technology roadmap, BOI investment strategy and partnerships with GE Healthcare and Siemens Healthineers—with planned capabilities spanning PET/CT, CT, MRI and Proton Therapy.
RESPONSIBILITIES
- PURPOSE: Defined the healthcare mission, brand purpose and patient promise for a new regional oncology destination.
- PATIENT EXPERIENCE: Designed the end-to-end journey across awareness, screening, diagnosis, treatment, recovery and continuing care—supported by family communication, digital engagement and personalised service.
- CLINICAL AND TECHNOLOGY ROADMAP: Defined the proposed oncology and nuclear-medicine capabilities across PET/CT, CT, MRI and a planned Proton Therapy programme.
- COMMERCIAL MODEL: Built the 7-year cost, pricing and revenue model required to evaluate investment viability and support long-term commercial sustainability.
- OPERATING MODEL: Designed the service-delivery model, organisational capabilities, patient pathways and operating requirements for the proposed 80-bed facility.
- STRATEGIC PARTNERSHIPS: Led partnership development and commercial negotiations with GE Healthcare and Siemens Healthineers to shape the medical-technology roadmap.
- INVESTMENT AND BOI STRATEGY: Developed the Thailand Board of Investment strategy covering investment incentives, tax concessions, regulatory alignment and international workforce requirements.
- MEDICAL TOURISM: Positioned the Phuket facility as a differentiated regional destination for advanced oncology, nuclear medicine and premium patient care.